NBIX logo

Neurocrine Biosciences (NBIX) Interest Expense

Annual Interest Expense

$4.60 M
-$2.50 M-35.21%

31 December 2023

NBIX Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

N/A

30 September 2024

NBIX Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

N/A

30 September 2024

NBIX TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBIX Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years-82.2%--
5 y5 years-85.6%--

NBIX Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-82.2%at low
5 y5 years-86.0%at low
alltimeall time-86.0%

Neurocrine Biosciences Interest Expense History

DateAnnualQuarterlyTTM
June 2024
-
$49.70 M(-44.7%)
$139.50 M(+55.3%)
Mar 2024
-
$89.80 M(>+9900.0%)
$89.80 M(+2541.2%)
Dec 2023
$4.60 M(-35.2%)
-
-
June 2023
-
$0.00(-100.0%)
$3.40 M(-39.3%)
Mar 2023
-
$1.10 M(0.0%)
$5.60 M(-21.1%)
Dec 2022
$7.10 M(-72.5%)
$1.10 M(-8.3%)
$7.10 M(-43.7%)
Sept 2022
-
$1.20 M(-45.5%)
$12.60 M(-30.0%)
June 2022
-
$2.20 M(-15.4%)
$18.00 M(-18.2%)
Mar 2022
-
$2.60 M(-60.6%)
$22.00 M(-14.7%)
Dec 2021
$25.80 M(-21.3%)
$6.60 M(0.0%)
$25.80 M(-4.4%)
Sept 2021
-
$6.60 M(+6.5%)
$27.00 M(-6.6%)
June 2021
-
$6.20 M(-3.1%)
$28.90 M(-6.8%)
Mar 2021
-
$6.40 M(-17.9%)
$31.00 M(-5.5%)
Dec 2020
$32.80 M(+2.5%)
$7.80 M(-8.2%)
$32.80 M(-1.2%)
Sept 2020
-
$8.50 M(+2.4%)
$33.20 M(+1.5%)
June 2020
-
$8.30 M(+1.2%)
$32.70 M(+1.2%)
Mar 2020
-
$8.20 M(0.0%)
$32.30 M(+0.9%)
DateAnnualQuarterlyTTM
Dec 2019
$32.00 M(+4.9%)
$8.20 M(+2.5%)
$32.00 M(+1.5%)
Sept 2019
-
$8.00 M(+1.3%)
$31.53 M(+1.1%)
June 2019
-
$7.90 M(0.0%)
$31.20 M(+1.0%)
Mar 2019
-
$7.90 M(+2.2%)
$30.90 M(+1.3%)
Dec 2018
$30.50 M(+56.2%)
$7.73 M(+0.8%)
$30.50 M(+1.0%)
Sept 2018
-
$7.67 M(+1.1%)
$30.19 M(+1.1%)
June 2018
-
$7.59 M(+1.2%)
$29.85 M(+10.4%)
Mar 2018
-
$7.50 M(+1.1%)
$27.03 M(+38.4%)
Dec 2017
$19.52 M(>+9900.0%)
$7.42 M(+1.1%)
$19.52 M(+61.3%)
Sept 2017
-
$7.34 M(+53.9%)
$12.10 M(+153.9%)
June 2017
-
$4.77 M(>+9900.0%)
$4.77 M(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sept 2016
-
$0.00(0.0%)
$0.00(0.0%)
June 2016
-
$0.00
$0.00
Dec 2015
$0.00(-100.0%)
-
-
Dec 2008
$7.03 M
-
-

FAQ

  • What is Neurocrine Biosciences annual interest expense?
  • What is the all time high annual interest expense for Neurocrine Biosciences?
  • What is the all time high quarterly interest expense for Neurocrine Biosciences?
  • What is the all time high TTM interest expense for Neurocrine Biosciences?

What is Neurocrine Biosciences annual interest expense?

The current annual interest expense of NBIX is $4.60 M

What is the all time high annual interest expense for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual interest expense is $32.80 M

What is the all time high quarterly interest expense for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly interest expense is $89.80 M

What is the all time high TTM interest expense for Neurocrine Biosciences?

Neurocrine Biosciences all-time high TTM interest expense is $139.50 M